ArticleScientific reports2026
Combined fortification of yogurt with grape pomace pectic oligosaccharides and encapsulated probiotics.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the effects of adding grape pomace pectic oligosaccharides (GPPOS) and Lactobacillus acidophilus (free and encapsulated) on different properties of synbiotic yogurts. GPPOS was incorporated at concentrations ranging from 0.1% to 1.4% (w/v) in yogurts as prebiotics, while free and encapsulated L. acidophilus were used as probiotics. The physicochemical, functional, survival rate and sensory characteristics were evaluated over 21 days of refrigerated storage. The formulation containing 0.4% GPPOS and encapsulated L. acidophilus exhibited significantly improved viscosity (1442.23 mPas), reduced syneresis (14.17%), enhanced antiradical scavenging activity (47.28%) and maintained probiotic viability under storage and simulated gastrointestinal conditions (≤ 0.65 log cfu/mL reduction). In addition, sensory evaluation showed improved acceptability at 0.1–0.7% GPPOS, although encapsulation reduced sensory scores. The findings of this study demonstrate the prebiotic potential of GPPOS and highlight the role of encapsulation in enhancing probiotic survival, physicochemical properties and overall functionality of synbiotic yogurts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.